Can a Week-Long wellness retreat boost cancer recovery?

NCT ID NCT07398079

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This pilot study is testing whether a 7-day integrative oncology retreat called 'Via Shalva' is practical and helpful for women who have finished primary treatment for breast or gynecologic cancer. Thirty participants will either attend the retreat or receive usual follow-up care. Researchers will measure how well the study runs and look for early signs of improvement in quality of life, stress, and other health markers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Integrative Cure Stay retreat (behavioral intervention)
What this could lead to
If successful, this could show that a short retreat combining complementary therapies and group support is a practical way to improve quality of life for cancer survivors.
What could go wrong
This is a very small pilot study (30 participants) focused on feasibility, not proof of benefit. Results may not apply to all survivors, and any improvements might be due to natural recovery or placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospital Basel

    RECRUITING

    Basel, 4031, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.